Telomere dynamics and telomerase activity in in vitro immortalised human cells

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 767-773

  Bryan, T M ^a   Reddel, R R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

immortalisation; senescence; telomerase; telomeres

Indexed keywords

TELOMERASE;

ARTICLE; CELL AGING; CELL IMMORTALIZATION; ENZYME ACTIVITY; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TELOMERE;

CELL AGING; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 0030990049     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00065-8     Document Type: Article

References (60)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25, 585-621.
2. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncogenesis 1994, 5, 331-357.
3. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366, 704-707.
4. Li Y, Nichols MA, Shay JW, Xiong Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994, 54, 6078-6082.
5. INK4 in human cancer. Proc Natl Acad Sci USA 1994, 91, 11045-11049.
6. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994, 9, 3375-3378.
7. INK4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer 1995, 61, 115-120.
8. INK4 MTS1 tumour suppressor gene product. EMBO J 1995, 14, 503-511.
9. INK4 expression in primary lung cancers and cell lines. Cancer Res 1995, 55, 505-509.
10. INK4 and telomerase in immortalisation of human cells. Oncogene 1995, 11, 971-976.
11. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O. Reznikoff C. Increased p16 levels correlate with pRB alterations in human urothelial cells. Cancer Res 1995, 55, 493-497.
12. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumem syndrome fibroblasts. Mol Cell Biol 1995, 15, 4745-4753.
13. INK4 expression. Oncogene 1996, 13, 1259-1268.
14. Girardi AJ, Jensen FC, Koprowski H. SV40-induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol 1965, 65, 69-84.
15. Shay JW, Van Der Haegen BA, Ying Y, Wright WE. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 1993, 209, 45-52.
16. Blackburn EH. Structure and function of telomeres. Nature 1991, 350, 569-573.
17. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345, 458-460.
18. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346, 866-868.
19. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256, 45-48.
20. Vaziri H, Schächter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
21. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Doklady Biochetn 1971, 201, 394-397.
22. Lansdorp PM, Verwoerd NP, Van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996, 5, 685-691.
23. Henderson S, Allsopp R, Spector D, Wang S-S, Harley C. In situ analysis of changes in telomere size during replicative aging and cell transformation. J Cell Biol 1996, 134, 1-12.
24. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
25. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995, 219, 130 136.
26. Cooke HJ, Smith BA. Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harbor Symp Quant Biol 1986, 51, 213-219.
27. Allshire RC, Gosden JR, Cross SH, et al. Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature 1988, 332, 656-659.
28. De Lange T, Shiue L, Myers RM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10, 518-527.
29. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43, 405-413.
30. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991, 256, 271-282.
31. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992, 27, 375-382.
32. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59, 521-529.
33. De Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994, 91, 2882-2885.
34. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992, 8, 193-197.
35. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
36. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68, 3410-3414.
37. Klnigelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK. Restoration of telomeres in human papillomavirus-immortalized human anogemtal epithelial cells. Mol Cell Biol 1994, 14, 961-969.
38. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
39. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 1995, 15, 425-432.
40. his). Oncogene 1996, 12, 715-725.
41. Holt SE, Gollahon LS, Willingham T, Barbosa MS, Shay JW. p53 levels in human mammary epithelial cells expressing wild-type and mutant human papillomavirus type 16 (HPV-16) E6 proteins: relationship to reactivation of telomerase and immortalization, Int J Oncol 1996, 8, 262-270.
42. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14, 4240-4248.
43. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996, 56, 645-650.
44. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994, 9, 3043-3048.
45. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994, 13, 4953-4962.
46. Härle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996, 93, 6476-6481.
47. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996, 380, 79-82.
48. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85, 2315-2320.
49. Broccoli D, Young JW, De Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92, 9082-9086.
50. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91, 9857-9860.
51. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988, 85, 6042-6046.
52. Lundblad V, Szostak JW. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989, 57, 633-643.
53. - senescence. Cell 1993, 73, 347-360.
54. Pluta AF, Zakian VA. Recombination occurs during telomere formation in yeast. Nature 1989, 337, 429-433.
55. Wang S-S, Zakian VA. Telomere-telomere recombination provides an express pathway for telomere acquisition, Nature 1990, 345, 456-458.
56. McEachern MJ, Blackburn EH. Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev 1996, 10, 1822-1834.
57. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer (Review). Int J Oncology 1995, 7, 423-432.
58. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996, 13, 161-166.
59. Murnane JP. Influence of cellular sequences on instability of plasmid integration sites in human cells. Somat Cell Mol Genet 1990, 16, 195-209.
60. Murnane JP, Yu L-C. Acquisition of telomere repeat sequences by transfected DNA integrated at the site of a chromosome break. Mol Cell Biol 1993, 13, 977-983.